← FDA Drug Approvals (Drugs@FDA)
CARBAMAZEPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2023-09-22
Drug application
- FDA Application #
ANDA212704- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBAMAZEPINE
- Generic name
- Carbamazepine
- Active ingredients
- CARBAMAZEPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AMNEAL PHARMS
- First approval
- 2023-09-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown